By Debdeep Gupta | 15 Sep, 2025
Alembic Pharma shares gain on EIR from USFDA for Panelav unit
Alembic Pharmaceuticals share price rose in the opening trade on September 15 following the company received establishment inspection report (EIR) post inspection by the US Food and Drug Administration (USFDA).At 09:20am, Alembic Pharmaceuticals was quoting at Rs 953.90, up Rs 8.10, or 0.86 percent, on the BSE.".... has EIR today for the inspection carried out conducted from 26th May, 2025 to 31st...
Live Comments
anbillion 2024-11-05 19:39:29
Shyam telecom Monday 32rs confirm hai November end 51rs confirm.
Login & Reply Like(0) Dislike(0) Repost Spamparvin 2022-08-02 17:29:59
superb results posted with increased revenue. eps also maintained equally. hold for long term, multifold returns will be generated.
Login & Reply Like(0) Dislike(0) Repost SpamA1FUTURE_TP1 2021-06-13 12:58:37
SGX Nifty showing level higher than 15000 now possible with getting strong global clues, our Channel continues to give the best Market updates
Login & Reply Like(0) Dislike(0) Repost Spam